Hill Research, a Princeton, New Jersey-based AI and life sciences firm, just received a significant vote of confidence from investor Covenant: a second major investment in the company. This move reflects Covenant’s sustained enthusiasm for Hill Research, which has reportedly quadrupled its revenue between 2024 and 2025.
Fourfold Revenue Growth Spurred Adoption
Hill Research achieved remarkable revenue growth between 2024 and 2025, increasing its earnings approximately fourfold. Over the same period, the company’s enterprise value doubled.
This impressive performance likely contributed to the expanding adoption of Hill Research’s solutions in the marketplace. As a result, Hill Research is well-positioned to continue growing its business in 2026.
Covenant Remains Committed to Hill Research
Covenant’s second investment in Hill Research signals its continued confidence in the company’s prospects. This decision demonstrates Covenant’s commitment to supporting high-growth portfolio companies, particularly those at the intersection of AI and life sciences.
Hill Research’s work in this space has resonated with Covenant, leading the investor to make a follow-on investment in the company. This move underscores Covenant’s willingness to provide sustained support to companies driving meaningful innovation in the industry.
What this Means for Tech Investors
The investment in Hill Research serves as a signal to other investors and companies operating in the AI and life sciences space. It highlights the potential for growth and adoption in this area, making it an attractive space for investors looking to capitalize on emerging trends.
As Hill Research continues to push the boundaries of AI and life sciences, its progress will be closely watched by investors and industry observers alike. Covenant’s sustained investment in the company underscores the potential for long-term growth and returns in this space.
